Primatene Mist epinephrine inhalers are next in line to be reformulated or pulled from the market

February 2009

Please see updated information from the FDA concerning the phase-out of CFC inhalers

Primatene Mist epinephrine inhalers are next in line to be reformulated or pulled from the market.

The current version will no longer be sold by the end of 2011 as part of the ban on CFC propellants. You'll probably get an HFA version by then.

This brings up the controversy as to whether asthma inhalers should be available OTC.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote